ReShape Lifesciences Inc. Share Price
Equities
RSLS
US76090R2004
Advanced Medical Equipment & Technology
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.167 USD | -0.60% | -0.18% | -33.12% |
12/04 | North American Morning Briefing : Big Banks Kick -2- | DJ |
01/04 | Transcript : ReShape Lifesciences Inc., Q4 2023 Earnings Call, Apr 01, 2024 |
Sales 2024 * | 9.99M 834M | Sales 2025 * | 11.99M 1B | Capitalization | 3.92M 327M |
---|---|---|---|---|---|
Net income 2024 * | -6M -501M | Net income 2025 * | -5M -417M | EV / Sales 2024 * | 0.39 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.33 x |
P/E ratio 2024 * |
-0.37
x | P/E ratio 2025 * |
-0.46
x | Employees | 29 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.83% |
Latest transcript on ReShape Lifesciences Inc.
1 day | -0.60% | ||
1 week | -0.18% | ||
Current month | +0.60% | ||
1 month | +1.40% | ||
6 months | -33.20% | ||
Current year | -33.12% |
Managers | Title | Age | Since |
---|---|---|---|
Paul Hickey
CEO | Chief Executive Officer | 59 | 01/20/01 |
Director of Finance/CFO | 63 | 15/21/15 | |
Dov Gal
CMP | Compliance Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Gary Blackford
BRD | Director/Board Member | 66 | 01/16/01 |
Dan Gladney
CHM | Chairman | 70 | 01/15/01 |
Director/Board Member | 70 | 15/21/15 |
Date | Price | Change | Volume |
---|---|---|---|
13/24/13 | 0.167 | -0.60% | 153,559 |
10/24/10 | 0.168 | +0.18% | 82,651 |
09/24/09 | 0.1677 | -4.17% | 84,901 |
08/24/08 | 0.175 | +0.52% | 241,469 |
07/24/07 | 0.1741 | +4.06% | 189,119 |
Delayed Quote Nasdaq, May 14, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.12% | 3.92M | |
+11.29% | 225B | |
+8.76% | 186B | |
+12.90% | 135B | |
+25.95% | 107B | |
+0.80% | 63.56B | |
+5.62% | 51.32B | |
+11.08% | 51.04B | |
+6.28% | 43.3B | |
+4.80% | 36.99B |
- Stock Market
- Equities
- RSLS Stock